SEC Form 4 · accession 0001127602-18-016117

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Corporate Executive VP & CFO

Period of report

May 1, 2018

Accepted (ET)

May 3, 2018 · 8:44 am EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	May 1, 2018	M	945	$51.45	A	13,723	D
Common Stock	May 1, 2018	S	100	$103.67	D	13,623	D
Common Stock	May 1, 2018	S	100	$103.73	D	13,523	D
Common Stock	May 1, 2018	S	100	$103.84	D	13,423	D
Common Stock	May 1, 2018	S	100	$104.11	D	13,323	D
Common Stock	May 1, 2018	S	100	$104.29	D	13,223	D
Common Stock	May 1, 2018	S	100	$104.33	D	13,123	D
Common Stock	May 1, 2018	S	100	$104.44	D	13,023	D
Common Stock	May 1, 2018	S	100	$104.53	D	12,923	D
Common Stock	May 1, 2018	S	5	$104.54	D	12,918	D
Common Stock	May 1, 2018	S	140	$104.87	D	12,778	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (Right to Buy)	$51.45	May 1, 2018	M	945	D	May 1, 2015	May 1, 2021	Common Stock	945	0	D